[1]
E. Angelina and S. B. Raharjo, “MOLNUPIRAVIR DAN NIRMATRELVIR/RITONAVIR SEBAGAI TERAPI ORAL COVID-19”, Jmb. Med. Journal: Jur. Ked. dan. Kes, vol. 10, no. 1, pp. 37–49, May 2022.